Home・Lista de Ações・Agilent Technologies Inc

Agilent Technologies Inc

Fechado

SetorSaúde

138.41 -0.22

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

137.27

Máximo

139.42

Indicadores-chave
By Trading Economics
Rendimento	34M 339M
Vendas	37M 1.8B
P/E Médio do Setor	27.745 64.641
EPS	1.49
Rendimento de Dividendos	0.73
Margem de lucro	18.474
Funcionários	18,000
EBITDA	44M 500M

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+12.11% upside

Dividendos
By Acuity
Rendimento de Dividendos Médio do Setor	0.73% 2.31%
Próximos Ganhos	26 de ago. de 2026
Próxima data de dividendos	21 de out. de 2026
Próxima data de ex-dividendo	29 de set. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	6.5B 39B
Abertura anterior	138.63
Fecho anterior	138.41

Sentimento de Notícias

By Acuity

30%

70%

102 / 340 Ranking em Healthcare

Agilent Technologies Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

31 de jul. de 2026, 20:03 UTC

Agilent Technologies Inc shares are lower today, impacted by a decline in the Life Sciences Tools & Services sub-sector. No specific news was identified.

30 de jul. de 2026, 19:58 UTC

Agilent Technologies Inc. is trading lower, continuing a decline since Wednesday's close. The Nasdaq 100 Index has increased, contrasting with Agilent's performance.

29 de jul. de 2026, 19:56 UTC

Agilent Technologies Inc shares are lower amid broader market pressures from rising crude oil prices and inflation concerns affecting equities.

28 de jul. de 2026, 23:41 UTC

Agilent Technologies shares declined in after-market trading, reflecting broader pressures in technology due to concerns over AI spending and competition from Chinese chipmakers.

27 de jul. de 2026, 22:36 UTC

Agilent Technologies Inc shares are higher in after-market trading, supported by strong performance. The stock remains above its 20-day moving average.

24 de jul. de 2026, 19:07 UTC

News

Agilent Technologies Inc shares are trading lower amid concerns over sales trends and underperformance compared to healthcare peers. The stock remains above its 20-day moving average.

23 de jul. de 2026, 20:03 UTC

Correlated Moves

News

Agilent Technologies received EU certification for its PD-L1 IHC 22C3 diagnostic, boosting shares during Thursday's session. This marks the eighth CE-marked indication in the EU.

22 de jul. de 2026, 21:46 UTC

Correlated Moves

Agilent Technologies Inc. is higher in after-market trading, supported by a rise in Thermo Fisher Scientific Inc. and overall life sciences sector performance.

21 de jul. de 2026, 20:02 UTC

News

Agilent Technologies has received FDA approval for its PD-L1 IHC 28-8 assay, boosting shares as analysts express positive sentiment on its future prospects.

20 de jul. de 2026, 19:22 UTC

News

Agilent Technologies Inc. shares are lower amid broader market declines and rising Treasury yields, despite a "Moderate Buy" consensus from analysts.

Comparação entre Pares

Variação de preço

Agilent Technologies Inc Previsão

Preço-alvo

By TipRanks

12.11% parte superior

Previsão para 12 meses

Média 155.13 USD 12.11%

Máximo 180 USD

Mínimo 135 USD

Com base em 16 analistas de Wall Street que oferecem metas de preço de 12 meses para Agilent Technologies Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

16 ratings

Comprar

Manter

Vender

Com base em 16 analistas que deram avaliações de ações para Agilent Technologies Inc - Dist nos últimos 3 meses.

Sentimento

By Acuity

102 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Agilent Technologies Inc

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.